These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9562265)

  • 21. Detection of anti-ganglioside antibodies in Guillain-Barré syndrome and its variants by the agglutination assay.
    Alaedini A; Briani C; Wirguin I; Siciliano G; D'Avino C; Latov N
    J Neurol Sci; 2002 Apr; 196(1-2):41-4. PubMed ID: 11959155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antiganglioside antibodies in the pathogenesis of autoimmune neuropathies].
    Kusunoki S
    Rinsho Shinkeigaku; 1999 Jan; 39(1):93-5. PubMed ID: 10377820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of commercial tests for detecting multiple anti-ganglioside autoantibodies in patients with well-characterized immune-mediated peripheral neuropathies.
    Caudie C; Quittard Pinon A; Bouhour F; Vial C; Garnier L; Fabien N
    Clin Lab; 2013; 59(11-12):1277-87. PubMed ID: 24409662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
    Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
    Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of Guillain-Barré syndrome with ophthalmoplegia showing high titers of anti-GQ1b and -GD1b antibodies in the serum].
    Hishida R; Baba M; Ozaki I; Matsunaga M; Saitoh T
    Rinsho Shinkeigaku; 1995 Mar; 35(3):306-8. PubMed ID: 7614756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal IgM reactive with several gangliosides in a chronic relapsing polyneuropathy.
    Brindel I; Preud'homme JL; Vallat JM; Vincent D; Vasquez JL; Jauberteau MO
    Neurosci Lett; 1994 Nov; 181(1-2):103-6. PubMed ID: 7534889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-GQ1b antibody syndrome: anti-ganglioside complex reactivity determines clinical spectrum.
    Fukami Y; Wong AH; Funakoshi K; Safri AY; Shahrizaila N; Yuki N
    Eur J Neurol; 2016 Feb; 23(2):320-6. PubMed ID: 26176883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Humoral immune response against Campylobacter jejuni lipopolysaccharides in Guillain-Barré and Miller Fisher syndrome.
    Jacobs BC; Endtz HP; van der Meché FG; Hazenberg MP; de Klerk MA; van Doorn PA
    J Neuroimmunol; 1997 Oct; 79(1):62-8. PubMed ID: 9357448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical spectrum of the anti-GQ1b antibody syndrome: a case series of eight patients.
    de Bruyn A; Poesen K; Bossuyt X; Heremans IP; Claeys T; Depuydt CE; Van Damme P; Claeys KG
    Acta Neurol Belg; 2019 Mar; 119(1):29-36. PubMed ID: 30747336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical presentation and outcome of Guillain-Barré and related syndromes in relation to anti-ganglioside antibodies.
    Carpo M; Pedotti R; Allaria S; Lolli F; Matà S; Cavaletti G; Protti A; Pomati S; Scarlato G; Nobile-Orazio E
    J Neurol Sci; 1999 Oct; 168(2):78-84. PubMed ID: 10526187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anti-glycoconjugate antibodies and dysglobulinemic or dysimmune peripheral neuropathies].
    Steck AJ; Kuntzer T
    Rev Neurol (Paris); 1996 May; 152(5):400-4. PubMed ID: 8881439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new line immunoassay for the multiparametric detection of antiganglioside autoantibodies in patients with autoimmune peripheral neuropathies.
    Conrad K; Schneider H; Ziemssen T; Talaska T; Reinhold D; Humbel RL; Roggenbuck D
    Ann N Y Acad Sci; 2007 Aug; 1109():256-64. PubMed ID: 17785314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic idiopathic sensory ataxic neuropathy: immunological aspects of a series of 17 patients.
    Illa I; Rojas R; Gallardo E; Serrano C; Graus F
    Rev Neurol (Paris); 2001 May; 157(5):517-22. PubMed ID: 11438771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome.
    Press R; Matá S; Lolli F; Zhu J; Andersson T; Link H
    J Neurol Sci; 2001 Sep; 190(1-2):41-7. PubMed ID: 11574105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical relevance of the determination of anti-GQ1b antibodies in Miller Fisher and Guillain-Barré syndromes.
    Goffette S; Jeanjean A; Pierret F; Peeters A; Sindic CJ
    Acta Neurol Belg; 1998 Dec; 98(4):322-6. PubMed ID: 9922819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-GQ1b IgG antibody syndrome: clinical and immunological range.
    Odaka M; Yuki N; Hirata K
    J Neurol Neurosurg Psychiatry; 2001 Jan; 70(1):50-5. PubMed ID: 11118247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA and anti-GQ1b IgG antibody in Miller Fisher syndrome and Guillain-Barré syndrome.
    Chiba A; Kusunoki S; Kuwata S; Juji T; Shibata Y; Kanazawa I
    J Neuroimmunol; 1995 Aug; 61(1):85-8. PubMed ID: 7560017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Autoantibodies in Guillain-Barré Syndrome].
    Uchibori A; Chiba A
    Brain Nerve; 2015 Nov; 67(11):1347-57. PubMed ID: 26560950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ataxic Guillain-Barré syndrome with anti-GQ1b antibody: relation to Miller Fisher syndrome.
    Yuki N; Susuki K; Hirata K
    Neurology; 2000 May; 54(9):1851-3. PubMed ID: 10802797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies].
    Tagawa Y; Matsumoto Y; Yuki N
    No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.